Jones Trading Reiterates Buy Rating on Enliven Therapeutics, Inc. (ELVN)

Market Context

Enliven Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $50.85 with a market capitalization of $1.1B.

Analyst coverage from Jones Trading provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Enliven Therapeutics, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Enliven Therapeutics, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 29, 2026	Jones Trading	Buy	N/A
Jun 09, 2026	Stifel	Buy	N/A
Jun 02, 2026	Mizuho	Outperform	N/A
May 08, 2026	Goldman Sachs	Buy	N/A
Mar 26, 2026	HC Wainwright & Co.	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View ELVN Stock Page